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ABSTRACT 
Cardiac myxoma often simulates multi system disease 
and initially defies diagnosis. In this paper, we present 
three cases of cardiac myxoma in adults. Their clinical 
features and differential diagnosis will be reviewed, with 
special emphasis on their insidiousness and suspicion 
necessary for correct and prompt diagnosis. The role of 
echocardiography in diagnosis and treatment will be 
discussed, and finally, the surgical management and 
prognosis is briefly outlined. 
INTODUCTION 
Tumours of the heart, while uncommon, present in 
protean ways and have challenged the acumen of physi­
cians since the seventeenth century. Antemortem diag­
nosis however, was rare before 1950 (1). This situation 
has changed with the advent of angiography and espe­
cially with non-invasive cardiac imaging techniques. 
Primary tumours of the heart are less common than 
secondary involvement by metastatic growth. Cardiac 
myxoma is the most frequent primary tumour and occurs 
with an incidence of 1-5 per 10,000 autopsies or 2 per 
100,000 of the general population. They are commoner 
in females and usually originate from the mural 
endocardium in the region of the fossa ovalis within the 
atria. Over 75% of them are located within the left 
atrium, 18% within the right atrium, 4% within the left 
ventricle and another 4% within the right ventricle. 
Although they are common between the ages of 30 and 
60, myxomas have been described in neonates, children 
and the elderly. Familial occurrence has been reported 
but cardiac myxomas are typically sporadic. 
Other benign primary cardiac tumours include: 
rhabdomyomas and fibromas (common in children and 
infants), papillary fibroelastomas, lipomas, meso­
theliomas of the atrioventricular node (which can cause 
sudden death from complete heart block or ventricular 
fibrillation), and, vasoformative tumours such as 
haemangiomas or lymphangiomas. Almost all primary 
malignant cardiac tumours are sarcomas, most frequentl y 
angiosarcomas. 
CASE PRESENTATION 
The three cases to be presented had come to the attention 
of the Medical Department of St. Luke's Hospital be­
tween April 1990 and March 1991. 
Case 1 (Fig. I and 11) A.M. was a previously perfectly 
healthy 40 year old female. She presented with a one 
month history of dyspnoea on mild exertion, palpita­
tions, anorexia and weight loss but no orthopnoea, par­
oxysmal nocturnal dyspnoea or ankle oedema. On ex­
amination she was found to be tachycardic, with a pulse 
rate of 120 beats/min, regular in rhythm and volume. 
Precordial auscultation revealed a loud first sound with 
a rumbling mid-diastolic murmur of grade 2/6 intensity 
at the apex. Clinical impression: mitral stenosis. 
FIG.! Long-axis parasternal view of case I. 

The myxoma lies within the left atrium and can be 

seen to almost obstruct the mitral valve orifice. 

a) 	 Routine 
ESR (mm 1st hr) 
Hgb (g/l) 
WBC (X 10 exp9/l) 
CXR 
ECG 
b) 	 Echocardiography 
Site 
Size (mm) 
Character 
Other features 
c) 	 Duration of symptoms 
from onset to diagnosis 
d) 	 Outcome 
CASE 1 
110 
11.3 
11.5 
Minimal cardiomegaly 
Sinus bradycardia 
P Mitra1e 
Left atrium 
33 x 35 
Pedunculated 
Slightly lobulated 
Right atrial enalrgement 
Moderate mitral and tricuspid 
regurgitation 
Pulmonary hypertension 
(Peak RV pressure =85 mmHg) 
1 month 
Operated 5 days after diagnosis 
- Excision of myxoma 
- Tricuspid valvuloplasty 
Patient is alive and well 
TABLE 1 
fCASE 2 
? 
14.5 
8.1 
Cardiomegaly 
Pulmonary venous congestion 
Sinus rhythm 
P mitrale 
Left atrium 
45 x 45 
Pedunculated 
Calcified borders 
Slight left ventricular 
hypertrophy 
9 months 
Operated 
I 
- Excision of myxoma 
I Patient is alive and well L __ 
CASE 3 
140 
10.1 (indices normal) 
6.8 
Moderate cardiomegaly 
Perihilar venous congestion 
Left lower zone shadow 
No pleural effusion 
New T Wave inversion 
in limb lead III 
Right atrium 
60 x 45 
Pedunculated 
Grossly lobulated 
Minimal, intermittent mitral 
regurgitation 
No pericardial effusion 
2 months 
Developed axillary vein 
thrombosis and anticoagulated 
Operated 5 days post-diagnosis 
Succumbed from massive 
pulmonary embolism post-op. 
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FIG.II M-mode view through the mitral valve orifice 
of case 1. The short echojree space between the 
mitral valve opening and the tumour can be seen. The 
cloud of tumour echoes behind the anterior mitral 
valve leaflet almost completely fills the mitral valve in 
diastole. 
Case 2 (Fig. III and IV) P.D. was a 64 year old female 
with a past history of hypercholesterolaemia, but no 
hypertension, diabetes mellitus or rheumatic fever, and 
no previous hospital admissions. She presented with two 
attacks ofpulmonary oedema following retrostemal pain 
and a choking sensation in the neck over a nine month 
period. Clinical impression: left ventriuclar failure sec­
ondary to coronary artery disease. 
FIG. III Apical4-chamber view of case 2. 

The left atrial myxoma lying at the mitral valve orifice. 
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FIG. IV Gross pathological appearance olthe left atrial 
myxoma excised from Case 2. Note the pedicle which 
was connecting the mass with the left atrium. 
Case 3 (Fig.V) P.M. was a 61 year old female with a past 
history of rheumatic fever in childhood and a right 
hydronephrosis due to pelvi-ureteric junction obstruc­
tion. She presented with a two month history of pyrexia 
( 1 00-1 02F) and a dry hacking cough associated with left­
sided pleuritic chest pain. On examination she was noted 
to be pale and showed signs of right-sided heart failure: 
elevated jugular venous pressure, tender hepatomegaly 
and gross lower limb oedema. A pericardial rub was 
heard on precordial auscultation. Clinical impression: 
recurrent pulmonary embolism. 
FIG. V Apical4-chamber view ofcase 3 
with annotated diagram on the extreme :::.:::¥ lV 
right. The tumour mass is seen to move Ifj.;.~~s(
vigorously in and out of the tricuspid 
valve orifice and can be seen to be <-<.:: LA 
!lA'multilobulated. 
'----..----­
Table 1 indicates the results of the relevant investiga­
tions carried out on these patients as well as their clinical 
outcome. In all three cases, the diagnosis was clinched by 
echocardiography after a time interval of between one 
and nine months . Figures 1 through 5, illustrate the gross 
pathological and echocardiographic appearance of the 
myxomas in these three cases. 
DISCUSSION 
a) Clinical features 
Intra-cavitary myxomas are characterized by a triad of 
clinical features: haemodynamic, embolic and constitu­
tional. 
The haemodynamic consequences derive from their pro­
pensity to obstruct the valvular orifice with resultant 
mitral or tricuspid stenosis, or, pulmonary vein obstruc­
tion. The patient may present with recent onset ofcardiac 
murmurs which progress rapidly without an obvious 
cause. Prolapse of the tumour through the valve orifice 
may transiently obstruct the blood flow to such an extent 
that the cardiac output falls and syncope or even sudden 
death occurs. Other common presenting features are 
exertional dyspnoea or palpitations. Frequently, the di­
agnosis of atrial myxoma comes as a surprise in a patient 
suspected clinically to have rheumatic mitral stenosis, as 
was the case in the first patient presented. It is reported 
that intra-cavitary myxomas continue to be seen in a 
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ratio of approximately I per 100 patients presenting for 
mitral valve surgery (2). Characteristically, the clinical 
course is relatively recent in origin, as was the case in our 
patient. This may help to distinguish atrial myxoma from 
rheumatic valve disease. 
Sometimes, the continual to-and-fro motion of a mobile 
tumour mass, especially if calcified, results in valvular 
leaflet damage with mitral or tricuspid regurgitation. 
This is known as the "wrecking ball" effect and may be 
severe enough to cause total destruction of the leaflets 
and require valve repair or even replacement (3). 
In none of our cases was a "tumour plop" specifically 
heard. This early diastolic sound resembles an opening 
snap and is produced by the impact of the mass on the 
ventricular wall. Occurrance of the plop requires a large 
enough mass or a long enough stalk to permit such an 
impact (4). Classically, the tumour plop varies with 
posture. 
Up to 40 or 50% ofpatients with atrial myxomas develop 
embolism of tumour fragments or surface clots. Sys­
temic emboli lodge in the arteries of the brain (5), 
kidneys or extremities, or even at the aortic bifurcation 
(6), retinal (7) or coronary arteries with resultant ischaemia 
or infarction. Indeed the second case presented might 
have been suffering from coronary artery embolization 
with angina and left ventricular failure. Emboli to the 
skin may mimic vasculitis and this may be the reason 
why the patient presents, often to a dermatologist (8, 9). 
Right-sided myxomas may embolize to the lungs, with 
resultant pulmonary infarction and/or pulmonary hyper­
tension. Case 3 was probably suffering from recurrent 
pulmonary emboli with pulmonary infarction and over­
lying pleural irritation. Paradoxical embolism may also 
occur to the systemic circulation via an atrial septal 
defect. All these emboli may be or become septic. 
The third element of the triad concerns the constitutional 
manifestations which occur in up to 90% ofpatients with 
cardiac myxomas, hence their reputation of being "the 
great simulators" of connective tissue disease. This sys­
temic upset occurs more frequently if the myxoma lies 
within the right atrium. However the presumed pro­
teinaceous substances released by the tumour into the 
circulation are removed or inactivated by the lungs. 
Interleukin-6 has been detected in the serum of patients 
with cardiac myxomas if they are accompanied by sys­
temic features. The levels were higher than those found 
in patients with active rheumatoid arthritis and dropped 
down to undetectable values when the myxomas were 
excised (10). This may be one of the agents responsible 
for the immunologic features simi I ar to those observed in 
true autoimmune diseases. 
Patients may suffer from pyrexia, weight loss, myalgia, 
arthralgia or fatigue. Typically, there is an accelerated 
sedimentation rate with elevated levels of IgG, with an 
anaemia (often haemolytic) or polycythaemia. There 
may also be leucocytosis, thrombocytopenia, clubbing 
and Raynaud's phenomenon. Generalized amyloidosis 
of the AA-type protein has been described (11). Auto­
antibodies with immune complex formation have also 
been found (12). 
Some of these features ofmulti system involvement were 
present in all the cases presented above, especially in the 
third patient who had very florid features of a systemic 
illness. Her pericardial rub suggested pericardi tis which 
was not associated with a pericardial effusion. 
Recently, a subset of patients with "syndrome myxoma" 
(13) or "Camey's complex" (14), has been distinguished 
from the larger group of patients with the commoner 
sporadic myxoma. This subset is characterized by the 
presence of multiple pigmented cutaneous lesions, non­
cardiac myxoid tumours or neurofibromas and multiple 
endocrine neoplasms (adrenal, testicular or pituitary). 
These patients are usually younger and often have af­
fected family members. 
b) Differential diagnosis 
Cardiac myxomas can simulate many other diseases and 
must therefore be considered in their differential diagno­
sis. Special care must be taken to exclude it in all cases 
of multi system disease, vasculitis, pyrexia of unknown 
origin, mitral or tricuspid valvular disease, as well as 
infective endocarditis or ischaemic heart disease. The 
correct diagnosis will be made if a high index of clinical 
suspicion is maintained in patients with diverse and. 
protean features, especially when cardiac, embolic and 
constitutional manifestations co-exist. 
c) Diagnostic methods 
Echocardiography can evaluate the exact size, shape, 
location and attachment site of the tumour, as well as the 
valvular integrity and myocardial function. Indeed, for 
many years, this was one of its most central roles. It is 
also used serially in patient follow-up. 2-D mode echo in 
real time is sufficiently reliable to permit immediate 
operative intervention without the need for additional 
invasive studies. It is now also being performed intra­
operatively via the trans-oesophageal route to provide 
guidance in the selection ofthe most appropriate surgical 
approach (15). In addition, trans-oesophageal 
echocardiography can better detect myxomas that are bi­
atrial or multiple or in the presence of chest deformity. 
Echocardiographic diagnosis is not al ways easy, as it can 
be very difficult to distinguish a myxoma from a ball 
thrombus. However, even in this latter case, surgical 
exploration is necessary. Doppler studies demonstrate 
the haemodynamic consequences by detecting the flow 
velocity patterns across the valvular orifices. 
Once a diagnosis of myxoma is made, a second concur­
rent tumour should always be carefully sought as multi­
ple tumours within the same heart are common (16). If 
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multi-centric tumours are in fact found, then all other 
members of the family should be screened echocardio­
graphically. 
The diagnosis may be confirmed by gatedradio-nucleide 
imaging techniques and/or by magnetic resonance 
imaging. 
If coronary artery disease is suspected. coronary 
angiography should be carried out. This may reveal 
neovascularisation (through branches of the coronary 
arteries) and outline the presence of shunts: left-to-Ieft 
through the tumour (17) or right-to-Ieft through a patent 
foramen ovale (18). Significant and operable coronary 
artery disease may be found, especially in the more 
elderly popUlation (19). Unfortunately, we lack details 
of the coronary angiography performed on case 2. 
d) Other investigations 
Possible clues to the diagnosis may be provided by the 
electrocardiogram and chest X-ray. The former may 
show evidence of atrial enlargement and pulmonary 
hypertension; the latter may reveal unusual bulges in the 
cardiac silhouette or normal sized heart in the presence 
of severe cardiac failure. 
e) Management and prognosis 
Surgical excision is the only acceptable form of treat­
ment that prevents tumour emboli and sudden death. 
Referral for excision becomes urgent when there is 
evidence of prior embolic events, when there have been 
syncopal attacks and when there is echocardiographic 
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